|
1
|
Ferlay J, Shin HR, Bray F, Forman D,
Mathers C and Parkin DM: Estimates of worldwide burden of cancer in
2008: GLOBOCAN 2008. Int J Cancer. 127:2839–2917. 2010. View Article : Google Scholar
|
|
2
|
Inra JA and Syngal S: Colorectal cancer in
young adults. Dig Dis Sci. 60:722–733. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Gross K and Brand MI: Genetic
predisposition to colorectal cancerCommon Surgical Diseases. New
York: Springer; pp. 189–191. 2014
|
|
4
|
August DA, Ottow RT and Sugarbaker PH:
Clinical perspective of human colorectal cancer metastasis. Cancer
Metastasis Rev. 3:303–324. 1984. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Belvitch P, Brown ME, Brinley BN, Letsiou
E, Rizzo AN, Garcia JGN and Dudek SM: The ARP 2/3 complex mediates
endothelial barrier function and recovery. Pulm Circ. 7:200–210.
2017. View
Article : Google Scholar : PubMed/NCBI
|
|
6
|
Yamaguchi H and Condeelis J: Regulation of
the actin cytoskeleton in cancer cell migration and invasion.
Biochim Biophys Acta. 1773:642–652. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Le Clainche C and Carlier MF: Regulation
of actin assembly associated with protrusion and adhesion in cell
migration. Physiol Rev. 88:489–513. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Firat-Karalar EN and Welch MD: New
mechanisms and functions of actin nucleation. Curr Opin Cell Biol.
23:4–13. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Goley ED and Welch MD: The ARP2/3 complex:
An actin nucleator comes of age. Nat Rev Mol Cell Biol. 7:713–726.
2006. View
Article : Google Scholar : PubMed/NCBI
|
|
10
|
Bailly M, Ichetovkin I, Grant W, Zebda N,
Machesky LM, Segall JE and Condeelis J: The F-actin side binding
activity of the Arp2/3 complex is essential for actin nucleation
and lamellipod extension. CurrBiol. 11:620–625. 2001. View Article : Google Scholar
|
|
11
|
Rauhala HE, Teppoi S, Niemelä S and
Kallioniemi A: Silencing of the ARP2/3 complex disturbs pancreatic
cancer cell migration. Anticancer Res. 33:45–52. 2013.PubMed/NCBI
|
|
12
|
Welch MD, DePace AH, Verma S, Iwamatsu A
and Mitchison TJ: The human Arp2/3 complex is composed of
evolutionarily conserved subunits and is localized to cellular
regions of dynamic actin filament assembly. J Cell Biol.
138:375–384. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Robinson RC, Turbedsky K, Kaiser DA,
Marchand JB, Higgs HN, Choe S and Pollard TD: Crystal structure of
Arp2/3 complex. Science. 294:1679–1684. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Higgs HN and Pollard TD: Regulation of
actin filament network formation through ARP2/3 complex: Activation
by a diverse array of proteins. Ann Rev Biochem. 70:649–676. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Otsubo T, Iwaya K, Mukai Y, Mizokami Y,
Serizawa H, Matsuoka T and Mukai K: Involvement of Arp2/3 complex
in the process of colorectal carcinogenesis. Mod Pathol.
17:461–467. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Ghosh A, Tousif S, Bhattacharya D,
Samuchiwal SK, Bhalla K, Tharad M, Kumar S, Prakash P, Kumar P, Das
G and Ranganathan A: Expression of the ARPC4 subunit of human
Arp2/3 severely affects Mycobacterium tuberculosis growth and
suppresses immunogenic response in murine macrophages. PLoS One.
8:e699492013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Xiong Y, Zhang H and Beach D: D type
cyclins associate with multiple protein kinases and the DNA
replication and repair factor PCNA. Cell. 71:505–514. 1992.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Goodlad RA: Quantification of epithelial
cell proliferation, cell dynamics and cell kinetics in vivo. Wiley
Interdiscip Rev Dev Biol. 6:2017. View
Article : Google Scholar : PubMed/NCBI
|
|
19
|
Xie Y, Li P, Gao Y, Gu L, Chen L, Fan Y,
Zhang F and Zhang X: Reduced E-cadherin expression is correlated
with poor prognosis in patients with bladder cancer: A systematic
review and meta-analysis. Oncotarget. 8:62489–62499. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Cao H, Xu E, Liu H, Wan L and Lai M:
Epithelial-mesenchymal transition in colorectal cancer metastasis:
A system review. Pathol Res Pract. 211:557–69. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Berx G and van Roy F: Involvement of
members of the cadherin superfamily in cancer. Cold Spring Harb
Perspect Biol. 1:a0031292009. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Abu Taha A and Schnittler HJ: Dynamics
between actin and the VE-cadherin/catenin complex: Novel aspects of
the ARP2/3 complex in regulation of endothelial junctions. Cell Adh
Migr. 8:125–135. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Chen A, Beetham H, Black MA, Priya R,
Telford BJ, Guest J, Wiggins GA, Godwin TD, Yap AS and Guilford PJ:
E-cadherin loss alters cytoskeletal organization and adhesion in
non-malignant breast cells but is insufficient to induce an
epithelial-mesenchymal transition. BMC Cancer. 14:5522014.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Kovacs EM, Goodwin M, Ali RG, Paterson AD
and Yap AS: Cadherin-directed actin assembly: E-cadherin physically
associates with the Arp2/3 complex to direct actin assembly in
nascent adhesive contacts. Curr Biol. 12:379–382. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Nijkamp MM, Span PN, Hoogsteen IJ, van der
Kogel AJ, Kaanders JH and Bussink J: Expression of E-cadherin and
vimentin correlates with metastasis formation in head and neck
squamous cell carcinoma patients. Radiother Oncol. 99:344–348.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Canel M, Serrels A, Frame MC and Brunton
VG: E-cadherin-integrin crosstalk in cancer invasion and
metastasis. J Cell Sci. 126:393–401. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Kuefer R, Hofer MD, Gschwend JE, Pienta
KJ, Sanda MG, Chinnaiyan AM, Rubin MA and Day ML: The role of an 80
kDa fragment of E-cadherin in the metastatic progression of
prostate cancer. Clin Cancer Res. 9:6447–6452. 2003.PubMed/NCBI
|
